Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Glaucoma Clinical Trials
Glaucoma clinical trials are recruiting across 94 cities. Here are the cities with the most active studies:
Glaucoma Trial Phases
50 research organizations are sponsoring glaucoma trials.
About Glaucoma
Glaucoma is a group of eye conditions that damage the optic nerve, often due to abnormally high eye pressure, and is a leading cause of irreversible blindness. Open-angle glaucoma is the most common form. Treatment includes eye drops, laser treatment, and surgery to lower eye pressure.
Clinical trials are advancing new treatments for glaucoma. Currently, 66 studies are recruiting a combined 28,126 participants across the United States. Research is being conducted by 50 organizations including Marc Toeteberg-Harms, Wills Eye, University of California, San Diego and 47 others.
2026 Glaucoma Research Landscape
As of July 2026, the glaucoma clinical trial landscape includes 66 actively recruiting studies across 94 cities in the United States. These studies are collectively seeking 28,126 participants, with an average enrollment target of 426 per study.
The research spans multiple phases of development: 26 studies are in NA, 11 studies are in PHASE4, 7 studies are in PHASE3, 3 studies are in PHASE1, 2 studies are in PHASE2, 2 studies are in EARLY_PHASE1. The presence of Phase 3 trials indicates that some glaucoma treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 50 different organizations, including Marc Toeteberg-Harms, Wills Eye, University of California, San Diego, Massachusetts Eye and Ear Infirmary, University of California, San Francisco, and 45 others. The large number of sponsors reflects significant research interest and investment in glaucoma treatment advancement.
Geographically, glaucoma trials are most concentrated in Baltimore, Maryland (7 trials); Philadelphia, Pennsylvania (4 trials); Boston, Massachusetts (4 trials); Newport Beach, California (4 trials); Glendale, Arizona (4 trials) and 7 other cities.
Featured Glaucoma Studies
Highlighted recruiting studies for glaucoma, selected by enrollment size and research scope.
Glaucoma Related Quality of Life
Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.
Novel Glaucoma Diagnostics
The purpose of this research is to evaluate novel technologies for the assessment of ocular structure and function, including the scanning device called Optical Coherence Tomography (OCT). We will test the OCT and other devices in their ability to image diseases of the eye and also compare the measurements made with OCT to those of other imaging and visual field devices approved by the Food and Dr...
Diagnostic Innovations in Glaucoma Study
The overarching goal of our research study is to evaluate changes in visual function and optic nerve topography (the structure of the back of the eye) in patients with glaucoma (increased susceptibility to pressure inside the eye that can cause loss of vision) or those with an increased risk of developing the disease. The purpose of this study is to determine the best methods for detecting the pre...
Frequently Asked Questions About Glaucoma Clinical Trials
Are there glaucoma clinical trials near me?
Yes, there are 66 glaucoma clinical trials currently recruiting across 94+ cities in the United States, including Baltimore, Maryland; Philadelphia, Pennsylvania; Boston, Massachusetts. Browse the studies above to find one at a location convenient for you.
How do I join a glaucoma clinical trial?
To join a glaucoma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are glaucoma clinical trials free?
Yes, participation in glaucoma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of glaucoma treatments are being studied?
Current glaucoma clinical trials are testing a range of approaches across NA (26 studies), PHASE4 (11 studies), PHASE3 (7 studies), PHASE1 (3 studies), PHASE2 (2 studies), EARLY_PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 50 research organizations.
Is it safe to participate in glaucoma clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov